Amy Carter, DO
Obstetrics & Gynecology · Kansas City, MONPI 1124121629
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $45,323 of the $48,885 with a category attached, or 92.7%. AbbVie accounts for 96.7% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $46,099 and has fallen 99.6% since, to $199 in 2025. Among obstetrics & gynecology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $223.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$47K
- Galderma Laboratories, L.p.$500
- Astellas Pharma US Inc$164
- Hologic Sales And Service, LLC$136
- Merz North America, Inc.$100
- Daiichi Sankyo Inc.$97
- plus $604 from 19 others
What the payments were for
- Speaking & faculty fees$45,32393%
- Food & beverage$3,5387%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 138 | $47,285 |
| Galderma Laboratories, L.p. | 24 | $500 |
| Astellas Pharma US Inc | 8 | $164 |
| Hologic Sales And Service, LLC | 7 | $136 |
| Merz North America, Inc. | 1 | $100 |
| Daiichi Sankyo Inc. | 6 | $97 |
| Channel Medsystems, Inc. | 1 | $70 |
| Avion Pharmaceuticals | 5 | $64 |
| Exeltis, USA Inc. | 4 | $56 |
| Organon | 3 | $51 |
| Therapeuticsmd, Inc. | 3 | $48 |
| Coopersurgical, Inc. | 3 | $43 |
| Medtronic | 1 | $38 |
| Amgen | 2 | $31 |
| Covidien LP | 2 | $30 |
| Evofem Biosciences, Inc. | 2 | $30 |
| Biogen | 1 | $21 |
| Pfizer | 1 | $17 |
| Merck | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Minerva Surgical, Inc | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Myovant Sciences Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$248
How this compares
$48,885 in reported general payments places this provider in the 95th percentile of 750 obstetrics & gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 54 | $5,338 |
| ProgesteroneProgesterone, Micronized | 77 | $2,805 |
| Estradiol | 27 | $2,660 |
| DottiEstradiol | 14 | $2,468 |
| Levothyroxine Sodium | 24 | $115 |
| Sertraline Hcl | 12 | $48 |
| Spironolactone | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Kansas City
- Lori KramerKansas City$11K
- Allyssa KaysKansas City$7K
- Thomas ShultzSpringfield$1.1M
- Becky LynnSaint Louis$231K
- Timothy HallIndependence$172K
- Craig McCoyMoberly$101K
- Richard GutknechtIndependence$65K
- Amanda CarrollFestus$55K
- Megan SneedLees Summit$44K
- Kimberly LemoineSaint Louis$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.